Haemonetics Corp has agreed to sell its whole blood assets to GVS for $44.6 million in cash and up to $22.5 million based on future sales growth, with the deal expected to close in early 2025.
AI Assistant
HAEMONETICS CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.